Company Filing History:
Years Active: 1990
Title: The Innovations of Benjamin A. Belinka
Introduction
Benjamin A. Belinka is an accomplished inventor based in Kendal Park, NJ (US). He has made significant contributions to the field of radiohalogenated compounds, which are essential for site-specific labeling in various applications. His work has implications in the development of radiohalogenated antibody conjugates, showcasing his expertise in the intersection of chemistry and biotechnology.
Latest Patents
Belinka holds a patent for "Radiohalogenated compounds for site specific labeling." This patent discloses radiohalogenated compounds that serve as intermediates for preparing radiohalogenated antibody conjugates. These compounds are specifically attached to an oxidized carbohydrate moiety of an antibody or antibody fragment. The patent also outlines methods for making these compounds and the antibody conjugates, as well as their methods of use. Notably, phenolic hydrazide and phenolic amine compounds are highlighted in this innovative work.
Career Highlights
Belinka is associated with Cytogen Corporation, where he has been able to apply his knowledge and skills in a collaborative environment. His work at Cytogen has allowed him to contribute to advancements in medical technology and therapeutic applications.
Collaborations
Throughout his career, Belinka has worked alongside notable colleagues such as Daniel J. Coughlin and Vernon L. Alvarez. These collaborations have further enriched his research and development efforts, leading to innovative solutions in the field.
Conclusion
Benjamin A. Belinka's contributions to the field of radiohalogenated compounds exemplify the impact of innovation in biotechnology. His patent and work at Cytogen Corporation highlight his role as a significant inventor in this specialized area.